Process for preparing substituted phenylisoxazoline derivatives

US10189799B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10189799-B2
Application numberUS-201615548216-A
CountryUS
Kind codeB2
Filing dateFeb 29, 2016
Priority dateMar 5, 2015
Publication dateJan 29, 2019
Grant dateJan 29, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for preparing substituted phenylisoxazoline derivatives.

First claim

Opening claim text (preview).

The invention claimed is: 1. Process for preparing one or more phenylisoxazoline derivatives of formula (I) wherein R 1 is methyl, bromomethyl or chloromethyl; R 2 is halogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkyl and R 3 is C 1 -C 4 -alkylsulphonyloxy, C 1 -C 4 -haloalkylsulphonyloxy, wherein, in (i), a chloroxime of formula (II) wherein R 4 is C 1 -C 12 -alkyl, is reacted with a styrene of formula (III) wherein R 2 and R 3 are as defined above, in the presence of an inorganic base in an organic aprotic solvent to give the corresponding phenylisoxazoline of formula (IV) wherein R 2 , R 3 and R 4 are as defined above, and the latter then reacts, in (ii), with an organometallic reagent and an organic base in an organic aprotic solvent to give the ketone of formula (Ia) wherein R 2 and R 3 are as defined above, and then, in (iii), in the presence of a halogenating agent in a solvent, the haloketone of formula (Ib) is formed wherein R 2 and R 3 are as defined above and X is chlorine or bromine. 2. Process according to claim 1 , wherein R 1 is methyl, bromomethyl, chloromethyl; R 2 is chlorine or bromine; R 3 is methylsulphonyloxy or ethylsulphonyloxy; R 4 is C 1 -C 4 -alkyl and X is chlorine or bromine. 3. Process according to claim 1 , wherein R 1 is methyl, bromomethyl; R 2 is chlorine; R 3 is methylsulphonyloxy; R 4 is methyl, ethyl and X is bromine. 4. Process according to claim 1 , wherein, in (ii), triethylamine is used as base and methylmagnesium bromide or methylmagnesium chloride as organometallic reagent.

Assignees

Inventors

Classifications

  • C07D261/08Primary

    with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

  • C07D261/04Primary

    having one double bond between ring members or between a ring member and a non-ring member · CPC title

  • five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10189799B2 cover?
The present invention relates to a process for preparing substituted phenylisoxazoline derivatives.
Who is the assignee on this patent?
Bayer Cropscience Aktiengesellschsaft, Bayer Cropscience Ag
What technology area does this patent fall under?
Primary CPC classification C07D261/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).